Navigation Links
MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
Date:9/24/2013

ficant impact on clinical outcome.

About MabVax Therapeutics, Inc.
MabVax Therapeutics, Inc. is a clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer.  MabVax is creating a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers. The company is based in San Diego, CA. MabVax recently closed its third round of Series B venture financing in July of this year. 

Forward Looking Statements

This press release contains "forward-looking statements" regarding matters that are not historical facts, including statements associated with MabVax's expectations regarding the results of this imaging research and the imaging product's potential commercial viability.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.  Words such as "anticipates," "plans," "expects," "intends," "will," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon MabVax's current expectations and involve assumptions that may never materialize or may prove to be incorrect.  Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties.


'/>"/>
SOURCE MabVax Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
11. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... N.H. , March 2, 2015 /PRNewswire/ ... provider of professional-grade vitamins, supplements, prescription products ... announced a strategic partnership with Anabolic Laboratories, ... for healthcare professionals. This new partnership will ... into new licensed healthcare practitioner segments and ...
(Date:3/2/2015)... March 2, 2015  BC Technical, the nation,s ... acquired Eclipse Systems, a Nuclear Imaging service company ... part of their ongoing vision to provide the ... rate, BC Technical continues to expand their reach ... to add valuable resources and knowledge in addition ...
(Date:3/2/2015)... Corporation (NYSE: XON ), a leader ... and full year results for 2014.  ... Acquired ActoGeniX, a European clinical stage biopharmaceutical company ... other innovative products.  Its proprietary TopAct™ platform enables ... lactis ) to generate biologically-contained ActoBiotics™ for in ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3BC Technical Acquires Eclipse Systems 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24
... Calif., Nov. 19 WaferGen Biosystems, Inc. (OTC ... genetic analysis systems, today announced a new, innovative ... using the SmartChip(TM) Real-Time PCR System. By ... WaferGen will offer universities, pharmaceutical and diagnostic companies ...
... , SAN DIEGO, Nov. 19 ... first point-of-care method for measuring platelet reactivity, announces that ... methods evaluated in the POPular study, which was presented ... American Heart Association,s annual Scientific Sessions. The VerifyNow P2Y12 ...
Cached Medicine Technology:WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 4VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests 2
(Date:3/3/2015)... 2015 HealthCarePoint (HCP) , ... announced today that it has completed development of ... Interchange Standards Consortium (CDISC). HCP will continue to ... knowledge-based training and certifications globally. HCP’s in-kind services ... support as well as development of dynamic identification ...
(Date:3/3/2015)... 03, 2015 Aureus Medical Group (web: ... jobs, has announced that it will participate as an ... Tuesday, March 17, 2015 in St. Louis, MO. , ... meet job-seeking residents and fellows in a comfortable, relaxed ... will be available to speak with attendees about ...
(Date:3/3/2015)... Join colleagues from across the continent at ... The Learning Summit is a working retreat for community ... explore strategies for focusing entire colleges on improving and ... at the Community College Research Center, Teachers College, Columbia ... Monday through Wednesday, the program will devote a half-day ...
(Date:3/2/2015)... Getting customers to discover a whole new world in ... the 31st annual Frozen Food Month kicks off. The ... Foods Association (NFRA) to stimulate the awareness and options ... frozen selections and is thrilled to be part of ... crafted with simple ingredients, no preservatives or artificial ingredients. ...
(Date:3/2/2015)... Dr. David Knepp, a leading chiropractor ... Doctors on Liens to bring his medical ... for personal injury victims to have access to multiple ... lien basis. However, San Diego Chiropractic Group ... M.D., pain management physician, massage, and acupuncture to help ...
Breaking Medicine News(10 mins):Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 2Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 3Health News:Register Today for the League for Innovation in the Community College’s Learning Summit 2015 2Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2
... the University of Pennsylvania School of Medicine in,Philadelphia, USA, has ... day have,impaired mental ability much similar to those who go ... was published in the March issue of the,journal Sleep involved ... hours a night for two weeks, the second group slept ...
... of Neurology, London has shown that,there are several preliminaries ... with migraine attacks that identification of these symptoms,would give ... it better.// ,The group of 97 participants were ... attack on a daily basis for three months. The ...
... rules that would help improve patient safety by reducing medication ... as many as 7,000 deaths. These errors have been attributed ... doctors on prescriptions, or too many new drugs for doctors ... 1999 study reported// between 45,000 and 98,000 death due to ...
... Stargardt's macular degeneration, also called juvenile macular degeneration, is ... people. This condition results from a defect in the ... protein that removes all-trans-retinaldehyde, a vision byproduct, from retinal ... retinal-pigmented epithelium (RPE), a layer of cells near the ...
... Health and Nutrition Examination Survey has now uncovered a ... is a form of gum disease that causes infection ... teeth. The participants of the study where divided into ... from the teeth, an indicator of the presence of ...
... heart beat, during recovery after exercise has been found ... increased risk of death and one that occurs during ... with no history of heart failure, valve disease or ... see if frequent ventricular ectopy occurred and when it ...
Cached Medicine News:
The opaque outer circle will white-out even the darkest iris, making your pupil the only spot of black in a sea of white....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Medpor Sphere Inserter. The Inserter is provided as a value added item to Medpor Orbital Implants....
Reusable blunt cannula with luer hub. Cannula length is 32 mm....
Medicine Products: